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The emerging importance of ultradian glucocorticoid rhythms within
metabolic pathology
L’importance émergente des rythmes glucocorticoïdes ultradiens dans la pathologie métabolique
Benjamin P. Flynn ∗, Becky L. Conway-Campbell , Stafford L. Lightman
Henry Wellcome Laboratories for Integrated Neuroscience and Endocrinology (HW LINE), University of Bristol, Dorothy Hodgkin Building, Whitson Street,
Bristol, BS1 3NY, United Kingdom
bstract
Glucocorticoid (GC) hormones play significant roles within homeostasis and the chrono-dynamics of their regulatory role has become increasingly
ecognised within dysregulated GC pathology, particularly with metabolic phenotypes. Within this article, we will discuss the relevance of the
ltradian homeostatic rhythm, how its dysregulation effects glucocorticoid receptor and RNA polymeraseII recruitment and may play a significant
ole within aberrant metabolic action.
2018 Les Auteurs. Publie´ par Elsevier Masson SAS. Cet article est publie´ en Open Access sous licence CC BY (http://creativecommons.org/
icenses/by/4.0/).
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ésumé
Les glucocorticoïdes (GC) jouent un rôle essentiel dans l’homéostasie. La chrono-dynamique de leur rôle régulateur est de plus en plus reconnue
ans les pathologies où les GC sont dérégulés, en particulier celles avec un phénotype métabolique. Dans cet article, nous discuterons de la
ertinence du rythme homéostatique ultradien, ainsi que les effets de son dysfonctionnement sur le récepteur des glucocorticoïdes, le recrutement
e l’ARN polymérase II et de son rôle important dans le développement de syndromes métaboliques.
2018 Les Auteurs. Publie´ par Elsevier Masson SAS. Cet article est publie´ en Open Access sous licence CC BY (http://creativecommons.org/
icenses/by/4.0/).
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. Endogenous Glucocorticoid rhythms
GC release is regulated by the hypothalamic pituitary adrenal
HPA) axis and plays key roles in circadian, stress, immunologi-
al, cognitive and metabolic regulation [1]. Circadian GC zenith
s prior to the active period, gradually decreasing to negligible
evels at the onset of the inactive period [2]. However, pha-
ic interplay between stimulatory feed-forward and inhibitory
eed-back mechanisms within the HPA axis produce naturally
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scillating GC pulses; establishing an ‘ultradian’ rhythm that
nderlies the circadian profile [3–5]. Fig. 1(A).
. HPA axis dysregulation
Loss of homeostatic GC release can have significant metabo-
ic implications. In Cushing disease cohorts, excessive constant
C production drives significant over-representations of obe-
ity, diabetes mellitus and dyslipidaemia phenotypes (32–41%,
0–47% and 38–71% respectively) [6,7]. Other instances of
ontinual increases in GC secretion such as three or more stress-
ul events a week, have been shown to increase the likelihood of
eveloping metabolic syndrome phenotypes, ∼2 fold [8]. Also,
ndications of insulin insensitivity are observed with increased
ost-prandial glucose and insulin levels more highly induced
access article under the CC BY license (http://creativecommons.org/licenses/
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Fig. 1. Ultradian glucocorticoid profile exposure directs glucocorticoid receptor binding and modulates RNA polymeraseII recruitment. (A) Blood plasma total
corticosterone (cort) levels in rats were sampled every 10 min through jugular cannulae via an automated blood sampling system over 24 hrs (14:10). On average,
max amplitudes of hourly pulses varied in a circadian fashion. Modified and re-drawn from Seale, J. V. et al.: Gonadectomy reverses the sexually diergic patterns
of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J Neuroendocrinol 2004;16:516–24, with permisson. © John
Wiley and Sons. (B) Hourly corticosterone (cort) bolus intravenous injections via jugular cannulae into adrenalectomised Sprague Dalwey rats induced rapid and
repeatable increases in circulating total cort blood plasma, returning to approximately baseline within 60 min. Resultant GR binding to the gene PER1 GRE and
hnRNA production in the liver peaked at 15 min and 30 min respectively, before returning to approximately basal levels by 60 min of each bolus. Plasma cort
samples were measured using an enzyme immunoassay. Modified and re-drawn from Stavreva, D. A., et al.: Ultradian hormone stimulation induces glucocorticoid
receptor-mediated pulses of gene transcription. Nat Cell Biol 2009;11:1093–102, with permission. © Springer Nature. (C) Sprague Dawley rats were infused hourly
with either a pulsatile pattern of cort (20 min infusion followed by 40 min cessation) or a matched constant pattern (infused over 60 min at 0.33 rate) at a dose of
3.84M. Liver samples were taken at 140 min or 180 min; corresponding to the peak and nadir of the third pulse. Vehicle infusions were used as control. (D) GR and
Pol2 enrichment was detected upstream (∼14.5 kb) and within intragenic regions respectively for the gene TSKU. Pulsatile cort induced time dependent increases
at the peak (140 min) of the third pulse for both GR and Pol2 enrichment; Pol2 enrichment in fact was reduced to Vehicle within the nadir (180 min) (adjusted
P-value $ <0.05, $$$ <0.001). Pattern dependent changes were detected at 180 min for GR whereas both Pol2 time points were significantly increased in response to
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4onstant infusion (adjusted P-value * <0.05, *** <0.001). Indicating both GR
mmunoprecipitation assays with either a GR or Pol2 antibodies were sequenced
ata was analysed to input control and compared to Veh (data un-published).
y bolus hydrocortisone injections at approximatly circadian
adir (17:00) compared to near circadian zenith (05:00) in adre-
ally suppresed cohorts. Potentially explaining an underlying
ause for the∼1.5 fold higher incidence of metabolic syndrome
henotypes in variable pattern shift workers [9,10].
. Dynamic glucocorticoid receptor regulation
GCs act via the ligand activated intracellular transcription
actor, the glucocorticoid receptor (GR). GR dynamic regula-
ion closely tracks the rising and falling levels in each GC pulse,
nd may therefore be highly sensitive to altered GC patterns
ssociated with dysregulated GC phenotypes. In vivo studies
a
m
G
rol2 recruitment to the gene TSKU is cort pattern dependent. Liver Chromatin
the Illumina HiSeq2000 platform and analysed using the Homer suite of tools.
bserved pulsatile GR recruitment to the period circadian clock
(PER1) gene’s GC response element (GRE) and similar pul-
atile nascent RNA production [11]; supporting the potential
or ultradian gene transcription within an endogenous system.
ig. 1(B).
. Loss of ultradian GR function
In the brain, the ultradian GC rhythm has been shown to play
critical role in maintaining the physiological, behavioural and
olecular response to an acute stress. Replacement of a pulsatile
C rhythm with a matched constant infusion significantly impai-
ed the adaptive response to the stressor [12]. It may therefore be
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et al. Genome wide ChIP-Seq analysis of Glucocorticoid Receptor
and RNA Polymerase 2 binding in rat liver during physiological and14 B.P. Flynn et al. / Annales d’E
ypothesized loss of, or alterations in the ultradian GC rhythm
ould also play a pivotal role within metabolism. Notably, syn-
hetic GCs (sGC) inhibit endogenous GC release and replace
ulsatile GR activation with prolonged profiles. In vitro experi-
ents demonstrated pulsatile corticosterone treatment induced
ransient GR:GRE binding (half-life∼8–9 min), yet binding per-
isted significantly longer in response to a range of sGC (> 3hr)
11,13]. In vivo (particularly in the liver) effects may be further
rolonged as sGC do not metabolise as rapidly as endogenous
Cs [14]. Similar experimental models have shown prolonged
onstant GR activation induced sustained RNA polymeraseII
Pol2) recruitment compared to a mock ‘ultradian’ profile over
selection of targets [15]. Further, in vivo studies within the rat
iver showed gluconeogenic and lipolytic pathways are subject
o complex and dynamic alterations in their expression patterns,
ependent upon pattern of GC exposure [16] Fig. 1(C-D).
. Conclusion
Ultradian GC action is highly sensitive to disruption and the-
efore could be equally integral to development of metabolic
henotypes. In support of this, GR and Pol2 recruitment in vitro
nd in vivo can be differentially modulated depending upon the
attern of cort exposure. New evidence currently emerging sug-
ests that the pattern of delivery, not just the dose, should be
onsidered when treating patients with sGC and that benefits
ould be garnered from ‘ultradian’ patterned therapies.
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